Fig. 3From: Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma A node containing Lafora disease is merged with nodes connected to it by an edge label of “I_CODE”: two Lafora disease related genes, the EPM2A gene, the EPM2B gene, and Metformin, a treatment that has been used for Lafora disease. The gray node is one of the merged nodes in the GBPN.Back to article page